KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cme (CME) Other Non-Current Assets (2016 - 2025)

Historic Other Non-Current Assets for Cme (CME) over the last 17 years, with Q3 2025 value amounting to $3.6 billion.

  • Cme's Other Non-Current Assets fell 145.2% to $3.6 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $3.6 billion, marking a year-over-year decrease of 145.2%. This contributed to the annual value of $3.5 billion for FY2024, which is 385.55% down from last year.
  • As of Q3 2025, Cme's Other Non-Current Assets stood at $3.6 billion, which was down 145.2% from $3.7 billion recorded in Q2 2025.
  • Cme's Other Non-Current Assets' 5-year high stood at $3.8 billion during Q3 2022, with a 5-year trough of $1.9 billion in Q2 2021.
  • For the 5-year period, Cme's Other Non-Current Assets averaged around $3.4 billion, with its median value being $3.7 billion (2023).
  • Its Other Non-Current Assets has fluctuated over the past 5 years, first plummeted by 533.57% in 2021, then skyrocketed by 9009.72% in 2022.
  • Cme's Other Non-Current Assets (Quarter) stood at $3.3 billion in 2021, then grew by 13.32% to $3.7 billion in 2022, then decreased by 0.78% to $3.7 billion in 2023, then dropped by 3.86% to $3.5 billion in 2024, then rose by 2.47% to $3.6 billion in 2025.
  • Its Other Non-Current Assets was $3.6 billion in Q3 2025, compared to $3.7 billion in Q2 2025 and $3.6 billion in Q1 2025.